We use cookies to provide you with the best possible experience. By using Orbitax's services, you agree that we may store cookies on your device. Cookie Policy.
The AI assistant for tax questions
Track worldwide tax law changes daily
Cross-border tax analysis and data
Unify and empower your entity management
Provides compliance steps, forms & rates
Visualize and manage your entity data
Comprehensive compliance management
Audit and global tax controversy tracking
Manage reportable cross-border arrangements
Country-by-country reporting & compliance
Pillar 2 planning, reporting and compliance
Calculate US tax impact of foreign operations
Automated workflows for recurring tax tasks
Secure API connections to 3rd-party systems
Secure storage for your tax documentation
Automated tax workflows with secure APIs.
Collaborate securely on your tax data
Share This Article
|
|
On August 16, 2018, the U.S. Court of Appeals for the Eighth Circuit filed its decision on the appeal of the Commissioner of Internal Revenue regarding the U.S. Tax Court decision that the IRS had made arbitrary, capricious, or unreasonable allocations under Section 482 between Minnesota-based Medtronic Inc. and its Puerto Rican subsidiary ({News-2017-05-01/A/3-previous coverage}). The main point of the appeal was the Commissioner's view that the Tax Court had erred in not applying the correct transfer pricing method when calculating the arm’s length royalty rates for Medtronic’s intercompany licenses. In its decision, the Tax Court had held that Medtronic's...